CBR1 Recombinant Antibody, AbBy Fluor™ 405 Conjugated
Product Specifications
Background
NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol.
Synonyms
CBR1; CRN; SDR21C1.
Gene ID
873
Swiss Prot
P16152
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
CBR1
Clonality
Recombinant
Conjugation
AbBy Fluor™ 405
Source
KLH conjugated synthetic peptide derived from human CBR1
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
401nm/421nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
873
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470158-500 1x 500 µL
Cytokeratin 17 (E3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC700391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF770 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881238-100 1x 100 µL
Napsin-A (NAPSA/1238), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680908-500 1x 500 µL
Tyrosinase (T311 + OCA1/812), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742176-500 1x 500 µL
MMP9 (rMMP9/1769), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details